Ascletis Pharma Inc. (1672.HK)
HKD 6.55
(3.15%)
HKD 6.55
(3.15%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 56.59 Million | 54.09 Million | 76.87 Million | 35 Million | 173.44 Million | 166.32 Million |
| Cost of Revenue | 30.6 Million | 78.78 Million | 37.7 Million | 58.49 Million | 49.16 Million | 12.37 Million |
| Gross Profit | 25.99 Million | -24.69 Million | 39.17 Million | -23.49 Million | 124.28 Million | 153.94 Million |
| Operating Expenses | 25.99 Million | 314.93 Million | 223.25 Million | 129.43 Million | 225.55 Million | 214.85 Million |
| Selling, General and Administrative Expenses | 62.96 Million | 32.41 Million | 37.36 Million | 47.79 Million | 125.04 Million | 144.42 Million |
| Research and Development Expenses | 216.78 Million | 267.1 Million | 213.32 Million | 109.09 Million | 125.96 Million | 143.45 Million |
| Other Expenses | - | 15.42 Million | -27.42 Million | -27.45 Million | -25.45 Million | -10.75 Million |
| Cost and Expenses | 363.4 Million | 393.71 Million | 260.95 Million | 187.93 Million | 274.71 Million | 227.23 Million |
| Operating Income | -306.81 Million | -262.81 Million | -195.89 Million | -156.42 Million | -36.44 Million | -60.91 Million |
| Interest Expense | 144 Thousand | 157 Thousand | 125 Thousand | 135 Thousand | 182 Thousand | - |
| Income Tax Expense | - | 51.86 Million | 3.12 Million | 52.81 Million | 59.52 Million | -125 Thousand |
| Earnings before Tax | -144.71 Million | -314.84 Million | -199.01 Million | -209.24 Million | -95.96 Million | -19.87 Million |
| Net Income | -144.71 Million | -366.71 Million | -202.13 Million | -262.05 Million | -155.49 Million | -7.25 Million |
| Earnings Per Share Basic | -0.13 | -0.34 | -0.18 | -0.25 | -0.15 | -0.01 |
| Earnings Per Share Diluted | -0.13 | -0.34 | -0.18 | -0.25 | -0.15 | -0.01 |
| Weighted Average Shares Outstanding | 1.07 Billion | 1.08 Billion | 1.09 Billion | 1.04 Billion | 1.05 Billion | 869.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.07 Billion | 1.08 Billion | 1.09 Billion | 1.04 Billion | 1.05 Billion | 869.04 Million |
| Gross Margin | 0.46 | -0.46 | 0.51 | -0.67 | 0.72 | 0.93 |
| EBIT Margin | -2.23 | -4.30 | -2.16 | -3.69 | -0.08 | -0.29 |
| Profit Margin | -2.56 | -6.78 | -2.63 | -7.49 | -0.90 | -0.04 |
| EBITDA | -126.09 Million | -284.49 Million | -169.34 Million | -181.94 Million | -73.63 Million | -48.93 Million |
| Earnings Before Tax Margin | -5.42 | -4.86 | -2.55 | -4.47 | -0.21 | -0.37 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 5.04 Million | 56.59 Million | 5.04 Million | 23.25 Million |
| Cost of Revenue | - | - | 11.36 Million | 30.6 Million | 11.36 Million | 3.94 Million |
| Gross Profit | - | - | -6.31 Million | 25.99 Million | -6.31 Million | 19.31 Million |
| Operating Expenses | 86.86 Million | 86.86 Million | 106.92 Million | 326.19 Million | 85.14 Million | 53.96 Million |
| Selling, General and Administrative Expenses | 20.67 Million | 20.67 Million | 44.66 Million | - | 44.66 Million | 13.34 Million |
| Research and Development Expenses | 66.19 Million | 66.19 Million | 62.26 Million | - | 62.26 Million | 46.12 Million |
| Other Expenses | - | - | - | -2.03 Million | - | - |
| Cost and Expenses | 86.86 Million | 86.86 Million | 118.28 Million | 356.8 Million | 96.5 Million | 57.91 Million |
| Operating Income | -86.86 Million | -86.86 Million | -113.24 Million | -308.94 Million | -114.05 Million | -40.41 Million |
| Interest Expense | - | - | - | 144 Thousand | - | 79.16 Thousand |
| Income Tax Expense | -99.5 Thousand | -99.5 Thousand | -816.5 Thousand | 95.4 Million | - | 12.09 Million |
| Earnings before Tax | -65.15 Million | -65.15 Million | -64.07 Million | -144.71 Million | -64.07 Million | -8.27 Million |
| Net Income | -65.15 Million | -65.15 Million | -64.07 Million | -144.71 Million | -64.07 Million | -8.27 Million |
| Earnings Per Share Basic | -0.06 | -0.06 | -0.06 | - | -0.06 | -0.01 |
| Earnings Per Share Diluted | -0.06 | -0.06 | -0.06 | - | -0.06 | -0.01 |
| Weighted Average Shares Outstanding | 1.01 Billion | 1.01 Billion | 1.06 Billion | 1.07 Billion | 1.06 Billion | 1.08 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.01 Billion | 1.01 Billion | 1.06 Billion | 1.07 Billion | 1.06 Billion | 1.08 Billion |
| Gross Margin | - | - | -1.25 | 0.46 | -1.25 | 0.83 |
| EBIT Margin | - | - | -21.97 | - | -21.97 | -1.57 |
| Profit Margin | - | - | -12.70 | -2.56 | -12.70 | -0.36 |
| EBITDA | -82.95 Million | -82.95 Million | -110.82 Million | - | -110.82 Million | -36.62 Million |
| Earnings Before Tax Margin | - | - | -22.45 | -5.46 | -22.61 | -1.74 |
MAHESHWARI
AZURF
PXA
OAL
HEWA
MNDP